Deigin, Yuri (Youth Bio 202209 CEO) |
Chief Executive Officer (CEO) |
Youth Bio |
|
Deininger, Sören-Oliver (Bruker 200905 Bruker Daltonics MALDI Imaging Specialist) |
n. a. |
Bruker (Group) |
United States (USA) |
Deininger, Werner (Entelechon GmbH 200709 Managing Director) |
Managing Director |
Eurofins (Group) |
Germany |
Dekeyser, Rudy (Life Sciences Partners 201403 Managing Partner LSP HEF) |
Managing Partner |
EQT (Wallenberg family) (Group) |
Netherlands |
Dekkers, Marijn E. (Novalis LifeSciences 202208 Chairman + Founder before Bayer CEO + Thermo Fisher CEO) |
Company Founder |
Novalis LifeSciences LLC |
United States (USA) |
Del Bono, Alessandro (Mediolanum 201612 CEO) |
Chief Executive Officer (CEO) |
Mediolanum (Group) |
Italy |
Del Bono, Cristina (Mediolanum 201612 Licensing + Business Development Director) |
Business Development Manager / Strategy Manager |
Mediolanum (Group) |
Italy |
del Castillo, Juan Carlos (Genetrix 201207 Operations Director) |
Chief Operating Officer (COO) |
2invest (Group) |
Spain (España) |
Del Fabro, Alessandro (Evolva 201807 VP Finance) |
Chief Financial Officer (CFO) |
Evolva (Group) |
Switzerland |
Delaite, Patricia (Nouscom 202002– CMO before Amal Therapeutics before Incyte + Ariad + Novartis + Eli Lilly) |
Chief Medical Officer (CMO) |
Nouscom (Group) |
Switzerland |
Delansorne, Rémi (Hybrigenics 201110 CEO) |
Chief Executive Officer (CEO) |
Hybrigenics (Group) |
France |
Delcourt, Marc (Global Bioenergies 201311 CEO) |
Chief Executive Officer (CEO) |
Global Bioenergies (Group) |
France |
Delenda, Christophe (Cellectis 201107 CSO of Cellectis Bioresearch) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Cellectis (Group) |
France |
Delepierre, Muriel (Institut Pasteur 201703 Professor) |
Professor |
Institut Pasteur |
France |
Della Chà, Alessandro (Cosmo Pharmaceuticals 201507 CEO) |
Chief Executive Officer (CEO) |
Cosmo Pharmaceuticals (Group) |
Luxembourg |
Dellapa, John (Neurimmune 201903– General Counsel before Mintz Levin Cohn Ferris Glovsky Popeo + Fisher Scientific) |
General Counsel / Chief Legal Officer (CLO) |
Neurimmune AG |
Switzerland |
Delporte, Olivier (Miracor 201801 CEO) |
Chief Executive Officer (CEO) |
Miracor (Group) |
Belgium |
Delvos, Ulrich (Curacyte 200811– CEO before 4y Medigene COO until 5/08 before Aventis Behring) |
Chief Executive Officer (CEO) |
Medigene (Group) |
Germany |
DeMan, Denise (Dee Dee) (Bench International 1974–201207– CEO + Founder) |
Chief Executive Officer (CEO) |
Bench International (Group) |
United States (USA) |
Dembowsky, Klaus (Amcure 201610 Managing Director) |
Managing Director |
Amcure GmbH |
Germany |
DeMesa, Jim (Emerald Health Pharmaceuticals 201902 CEO) |
Chief Executive Officer (CEO) |
Emerald Health Pharmaceuticals Inc. |
United States (USA) |
Deml, Ludwig (Lophius Biosciences 201011 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Mikrogen GmbH |
Germany |
Demorest, Robert L. (MOCON Inc 201704 CEO) |
Chief Executive Officer (CEO) |
AMETEK (Group) |
United States (USA) |
Demuth, Hans-Ulrich (Probiodrug 1997 founder + CSO 2008) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Vivoryon (Group) |
Germany |
Demuth, Ronald (ChemDiv 202208 CEO formerly 200810 SVP Corporate Development) |
Business Development Manager / Strategy Manager |
ChemDiv Inc. (Chemical Diversity Labs) |
United States (USA) |
Demuth, Tim (MorphoSys 202210– promoted to Chief RnD Officer joined 2017 before Pieris + Merck KGaA + Sandoz) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
MorphoSys (Group) |
Germany |
Denat, Didier (Swiss Entrepreneurs Fund 202004 + Credit Suisse (Switzerland) Ltd 202004) |
n. a. |
Credit Suisse (Group) |
Switzerland |
Dengler, Wolfgang (Bavaria (govt) 201410 Bayern Kapital) |
Investment Manager |
Bavaria (govt region) |
Germany |
Denisov, Eduard (Thermo Fisher 201202 Thermo Fisher Scientific (Bremen) GmbH) |
n. a. |
Thermo Fisher (Group) |
Germany |
Dennig, Jörg (Qiagen 201201 Global Product Manager RNAi) |
Product Manager (personnel) |
Qiagen (Group) |
Germany |
Dennison, Stephanie (Cellbox Solutions 202107– Business Development Manager US before Chromotek Inc) |
Business Development Manager / Strategy Manager |
Cellbox Solutions (Group) |
United States (USA) |
Dennstedt, Sascha C. (Quantapore 201406 President BusDev before VBC-Biotech 201104 Managing Director) |
Business Development Manager / Strategy Manager |
Quantapore Inc. |
United States (USA) |
Densow, Holger (Biometra 200809) |
n. a. |
Endress+Hauser (Group) |
Germany |
Deperthes, David (Debiopharm 201306 VP Business Development) |
Business Development Manager / Strategy Manager |
Debiopharm (Group) |
Switzerland |
Deptula-Hicks, Darlene (Pieris 201509–201702 CFO before consultant to Pieris RESIGNED 2/17) |
Chief Financial Officer (CFO) |
Pieris (Group) |
United States (USA) |
Derouazi, Madiha (Amal Therapeutics 201209– CEO + Founder) |
Chief Executive Officer (CEO) |
Boehringer Ingelheim (Group) |
Switzerland |
Desai, Neil (Aadi Bioscience 201705 CEO + Founder before Celgene) |
Chief Executive Officer (CEO) |
Aadi Bioscience Inc. |
United States (USA) |
DeScenza, Lisa (LaVoie Health Science 201901) |
Public Relations Manager / Investor Relations Manager |
LaVoieHealthScience (LHS) |
United States (USA) |
Deschamps, Lisa (AviadoBio 202111– CEO before Novartis Gene Therapies) |
Chief Executive Officer (CEO) |
AviadoBio Ltd. |
United Kingdom (GB) |
Deschner, Alexandra (Consilium 202303– Senior Strategic Advisor before Univercells + Mithra Pharma + UCB + Fiat) |
Public Relations Manager / Investor Relations Manager |
ICR (Group) |
United Kingdom (GB) |
Deshpande, Shashank (Boehringer 202401– Managing Director Animal Health Business Unit before Managing Director Japan) |
Managing Director |
Boehringer Ingelheim (Group) |
Germany |
Desrochers, Stacey (Bruker 201009 Director Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Bruker (Group) |
United States (USA) |
Detemble, Charlotte (Patronus Health 202204 Managing Director (CFO) + Co-Founder) |
Chief Financial Officer (CFO) |
Patronus Health GmbH |
Germany |
Detmers, Jan (Zellkraftwerk 201412– Managing Director joined 201402– before Chimera Biotec + Molzym ) |
Managing Director |
Doppelganger Biosystem GmbH |
Germany |
Dettmer, Alexander (Rentschler 202007– CFO before Fresenius) |
Chief Financial Officer (CFO) |
Rentschler (Group) |
Germany |
Deutsch, Ulla (Qiagen 200909 Senior Global Product Manager Amplification) |
Product Manager (personnel) |
Qiagen (Group) |
Germany |
Devidts, Gilles (SOTAX 201003 Head Product Management) |
Product Manager (personnel) |
Sotax (Group) |
Switzerland |
Devoy, Michael (Bayer 201707 CMO + Head of Medical Affairs + Pharmacovigilance at Bayer Pharma) |
Chief Medical Officer (CMO) |
Bayer (Group) |
Germany |
Dey, Neil (Definiens 200507– joined from Bioimagene) |
n. a. |
AstraZeneca (Group) |
Germany |
Dezulian, Tobias (Computomics 201301 Managing Director + Co-founder) |
Managing Director |
Computomics (Group) |
Germany |
Dhaliwal, Kam (Horizon Discovery 201108 Director Business Development before Evotec + Acumen Bioscience) |
Business Development Manager / Strategy Manager |
PerkinElmer (Group) |
United Kingdom (GB) |
Dhar, Rakhshita (Bayer 202206 Senior Director of Venture Investments Health at Leaps by Bayer) |
Investment Manager |
Bayer (Group) |
|
Dharmadhikari, Kartik (Novo Group 202105 Partner at Novo Growth) |
Partner (venture partner) |
Novo Group (Group) |
Denmark |
Dhawan, Vinod (Lupin 201409 Group President Asia Pacific + Africa + Middle East + Latin America) |
Sales Manager / Marketing Manager |
Lupin (Group) |
India |
Di Cesare, Silvana (CMC Biologics 201511 Director Business Development before Capsulution Nanoscience 200705 BusDev) |
Business Development Manager / Strategy Manager |
Asahi Glass (AGC) (Group) |
Denmark |
Di Giorgio, Paolo (Angelini 202209 CEO + Managing Director of Angelini Ventures) |
Chief Executive Officer (CEO) |
Angelini (Group) |
Italy |
Di Naro, Antonio Francesco (Adienne 201205 VEP + Founder) |
Chief Executive Officer (CEO) |
Adienne (Group) |
Italy |
Di Nepi, Giacomo (Polyphor 201611–202001 CEO before InterMune + Takeda + McKinsey RETIRED 1/20) |
Chief Executive Officer (CEO) |
Spexis (Group) |
Switzerland |
Diaz, Allene M. (Tesaro 201609 SVP Global Commerical Developm before Merck Serono + Biogen Idec + Pfizer) |
Chief Commercial Officer (CCO) |
GSK (Group) |
United States (USA) |
Dible, David (Huntsworth 201506 Senior Director Life Sciences at Citigate Dewe Rogerson London) |
Public Relations Manager / Investor Relations Manager |
Inizio (Group) |
United Kingdom (GB) |
Dibowski, Annette (dichrom GmbH 201003 Managing Director) |
Managing Director |
Dichrom GmbH |
Germany |
Dibowski, Harald (dichrom GmbH 201003 Managing Director) |
Managing Director |
Dichrom GmbH |
Germany |
Dieckhoff, Patrick (Biocom 201104– Editor + Managing Director Biocom Media GmbH) |
Managing Director |
Biocom (Group) |
Germany |
Dieckmann, Florian (Grünenthal 202104 Head Global Communications) |
Public Relations Manager / Investor Relations Manager |
Grünenthal (Group) |
Germany |
Diefenthal, Thomas (BioPark Regensburg 201103 Managing Director) |
Managing Director |
Regensburg (govt city) |
Germany |
Diehl, Anne (Leibniz-Gemeinschaft 201112 Leibniz Institute for Molecular Pharmacology) |
Researcher (university / research institute) |
Leibniz-Gemeinschaft |
Germany |
Diehl, Frank (Inostics GmbH 2013 Managing Director + Co-Founder) |
n. a. |
Sysmex (Group) |
Germany |
Diehl, Hans-Josef (A&M Labor 201201 Managing Director of A & M STABTEST) |
Managing Director |
A&M Labor für Analytik (Group) |
Germany |
Diekmann, Johannes (Diekmann 201304 Managing Director Diekmann Seeds) |
Managing Director |
Dieckmann GmbH & Co. KG |
Germany |
Diels, Bart (Gimv 201603 Head of Gimv Health & Care platform) |
Investment Manager |
Gimv (Group) |
Belgium |
Dieners, Peter (Clifford Chance 200809 Dusseldorf) |
n. a. |
Clifford Chance (Group) |
Germany |
Dierks, Kai (Soventec GmbH 201209 Managing Director) |
Managing Director |
Soventec GmbH |
Germany |
Diete, Wolfgang (Bruker 200909 Bruker ASC GmbH) |
n. a. |
Bruker (Group) |
Germany |
Dietel, Manfred (Charité 201303 Director at Institute of Pathology) |
Professor |
Humboldt University Berlin |
Germany |
Dietrich, Guido (Virion Biotherapeutics 201812– Head of Manufacturing before MSD + Novartis + GSK + Lonza) |
Production Manager |
Virion Biotherapeutics Ltd. |
United Kingdom (GB) |
Dietrich, Reinhard (Bruker 201205 Managing Director of Bruker HTS GmbH) |
Managing Director |
Bruker (Group) |
Germany |
Dietsch, Johannes (Bayer 201410–201805 CFO before Bayer Greater China joined Bayer 1984 LEFT 5/18) |
Chief Financial Officer (CFO) |
Bayer (Group) |
Germany |
Dietz, Hendrik (TU Munich 202211 Professor + Co-Founder of Plectonic Biotech) |
Professor |
Technical University Munich (TU München, TUM) |
Germany |
Dietzsch, Ulrich (Golm Innovationszentrum 201104 Managing Director) |
Managing Director |
Golm Innovationszentrum GmbH (GO:IN) |
Germany |
Digel, Susanne (Bluebird Bio 202004 Managing Director at Bluebird Bio (Germany) GmbH before Spark + Alexion) |
Managing Director |
Bluebird Bio (Group) |
Germany |
Diggelmann, Roland (Roche 201209–201809 CEO of Roche Diagnostics before Head Asia-Pacific LEFT 9/18) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
Dijk, Hans (Scienion 200906– Sales Manager) |
Sales Manager / Marketing Manager |
Bico (Group) |
Germany |
Dikic, Ivan (Vivlion GmbH 202004 Managing Director (CEO) + Co-Founder + Prof at Univ Frankfurt) |
Managing Director |
Vivlion GmbH |
Germany |
DiLaura, Peter (Sonoma Biotherapeutics 202002 Chief Business + Strategy Officer formerly Ingenuity 200603) |
Chief Business Officer (CBO) |
Sonoma Biotherapeutics Inc. |
United States (USA) |
Dill, Donald Nelson (A&M Labor 201201 Managing Director of A & M STABTEST) |
Managing Director |
A&M Labor für Analytik (Group) |
Germany |
Dill, Matthias (High-Tech Gründerfonds 201112 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
Dillione, Janet (Siemens 200703 President Health Service) |
n. a. |
Siemens (Group) |
Germany |
Dilly, Stephen (Sierra Oncology 202204 CEO formerly Aimmune Therapeutics 201611–201806 CEO + Chiron BioPharma) |
Chief Executive Officer (CEO) |
GSK (Group) |
United States (USA) |
DiMartino, Jorge (Celgene 201810 VP Translational Development Oncology) |
n. a. |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
Dimson, Phil (SPEware 201608 CEO + Founder) |
Chief Executive Officer (CEO) |
Tecan (Group) |
United States (USA) |
Dineen, John (General Electric 200807– GE Healthcare CEO before GE Transportation CEO before GE Advanced Materials) |
Chief Executive Officer (CEO) |
General Electric (Group) |
United Kingdom (GB) |
Ding, Simone (Biocom 201010 Biocom Media GmbH) |
Editor / Publisher |
Biocom (Group) |
Germany |
Dingermann, Theodor Prof. (Protagen 200706 Board member) |
Professor |
University of Frankfurt (Goethe-Universität) |
Germany |
Dinkelborg, Ludger (Piramal 201204– Managing Director of Piramal Imaging GmbH) |
Managing Director |
Life Healthcare Group (Group) |
Germany |
Dinter, Harald (Bayer 201405 Head of Global Biologics at Bayer Pharma AG) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
Dionne, Dennis (Newron 201701– VP Commercial Affairs before JnJ + Novartis) |
Chief Commercial Officer (CCO) |
Newron (Group) |
Italy |
Dirkes-Kersting, Astrid (Hygel 201705 Managing Director) |
Managing Director |
Eurofins (Group) |
Germany |
Dirnagl, Ulrich (Charité Berlin 201704 Professor + BIH) |
Professor |
Humboldt University Berlin |
Germany |
Disley, Darrin M. (Mogrify 201902– CEO of Cell Mogrify Ltd before 11 years at Horizon Discovery) |
Chief Executive Officer (CEO) |
Mogrify (Group) |
United Kingdom (GB) |
Distelrath, Judith (Wacker 201602 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Wacker (Group) |
Germany |